Dexcom Inc <DXCM.O>: Argus Research Raises Target Price by $10 to $96
DXCM•Related News
Bristol-Myers Squibb announces dividend of R$ 2.11 per unit for Q3 2026
BMY•
Allogene Therapeutics schedules quarterly results, business update call
ALLO•
V2X wins USD 500 million ceiling U.S. Air Force C-12 sustainment contract
VVX•
Backblaze, Inc. <BLZE.O>: Oppenheimer Raises Target Price To $25 From $15
BLZE•
Schwab survey shows U.S. stock market bullish sentiment jumps to 47% in Q3 2026
SCHW•